Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Agonistic CD40 Antibodies in Cancer Treatment.
Djureinovic D, Wang M, Kluger HM. Djureinovic D, et al. Among authors: kluger hm. Cancers (Basel). 2021 Mar 15;13(6):1302. doi: 10.3390/cancers13061302. Cancers (Basel). 2021. PMID: 33804039 Free PMC article. Review.
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance.
Schoenfeld DA, Merkin RD, Moutafi M, Martinez S, Adeniran A, Kumar D, Jilaveanu L, Hurwitz M, Rimm DL, Kluger HM. Schoenfeld DA, et al. Among authors: kluger hm. Front Oncol. 2022 Oct 13;12:990367. doi: 10.3389/fonc.2022.990367. eCollection 2022. Front Oncol. 2022. PMID: 36313654 Free PMC article.
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
Schoenfeld DA, Moutafi M, Martinez S, Djureinovic D, Merkin RD, Adeniran A, Braun DA, Signoretti S, Choueiri TK, Parisi F, Hurwitz M, Rimm DL, Wei W, Jilaveanu L, Kluger HM. Schoenfeld DA, et al. Among authors: kluger hm. J Immunother Cancer. 2023 Aug;11(8):e007240. doi: 10.1136/jitc-2023-007240. J Immunother Cancer. 2023. PMID: 37586773 Free PMC article.
CD70 expression patterns in renal cell carcinoma.
Jilaveanu LB, Sznol J, Aziz SA, Duchen D, Kluger HM, Camp RL. Jilaveanu LB, et al. Among authors: kluger hm. Hum Pathol. 2012 Sep;43(9):1394-9. doi: 10.1016/j.humpath.2011.10.014. Epub 2012 Mar 7. Hum Pathol. 2012. PMID: 22401771 Free PMC article.
GP100 expression is variable in intensity in melanoma.
Mann JE, Hasson N, Su DG, Adeniran AJ, Smalley KSM, Djureinovic D, Jilaveanu LB, Schoenfeld DA, Kluger HM. Mann JE, et al. Among authors: kluger hm. Cancer Immunol Immunother. 2024 Aug 6;73(10):191. doi: 10.1007/s00262-024-03776-5. Cancer Immunol Immunother. 2024. PMID: 39105816 Free PMC article.
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
Su DG, Schoenfeld DA, Ibrahim W, Cabrejo R, Djureinovic D, Baumann R, Rimm DL, Khan SA, Halaban R, Kluger HM, Olino K, Galan A, Clune J. Su DG, et al. Among authors: kluger hm. J Immunother Cancer. 2024 Mar 21;12(3):e008646. doi: 10.1136/jitc-2023-008646. J Immunother Cancer. 2024. PMID: 38519058 Free PMC article.
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1.
Weiss SA, Djureinovic D, Jessel S, Krykbaeva I, Zhang L, Jilaveanu L, Ralabate A, Johnson B, Levit NS, Anderson G, Zelterman D, Wei W, Mahajan A, Trifan O, Bosenberg M, Kaech SM, Perry CJ, Damsky W, Gettinger S, Sznol M, Hurwitz M, Kluger HM. Weiss SA, et al. Among authors: kluger hm. Clin Cancer Res. 2021 Sep 1;27(17):4757-4767. doi: 10.1158/1078-0432.CCR-21-0903. Epub 2021 Jun 17. Clin Cancer Res. 2021. PMID: 34140403 Free PMC article. Clinical Trial.
240 results